Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-11-070129
Filing Date
2011-12-19
Accepted
2011-12-19 17:03:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 S-3/A a11-31527_1s3a.htm S-3/A 419100
2 EX-23.2 a11-31527_1ex23d2.htm EX-23.2 3716
  Complete submission text file 0001104659-11-070129.txt   424011
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-177730 | Film No.: 111269803
SIC: 2834 Pharmaceutical Preparations